Xealth Funding: $50M Raised, IPO (2025)

Xealth funding overview

Xealth is based in Seattle, Washington. Xealth has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is an IPO announced in July 2025. The round record for Xealth runs through 2025; nothing later has been disclosed. Investors on record include DFJ, Providence Ventures, UPMC, Froedtert and Medical College of Wisconsin Health Network, Atrium Health, Cleveland Clinic and 6 others. 12 distinct backers are named across the disclosed rounds.

Xealth at a glance

Total raised: $50M
Latest round: IPO
Latest round date: July 2025
Headquarters: Seattle, Washington
Notable investors: DFJ, Providence Ventures, UPMC, Froedtert and Medical College of Wisconsin Health Network, Atrium Health, Cleveland Clinic, MemorialCare Innovation Fund, McKesson Ventures

Frequently asked about Xealth funding

How much has Xealth raised?: Xealth has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Xealth?: DFJ, Providence Ventures, UPMC, Froedtert and Medical College of Wisconsin Health Network, Atrium Health, Cleveland Clinic are named among the investors backing Xealth.
What was the latest Xealth funding round?: The most recent disclosed round is an IPO, announced in July 2025.
Where is Xealth based?: Xealth is based in Seattle, Washington.
When did Xealth last raise?: The last disclosed Xealth round closed in July 2025 at IPO.

We update the Xealth record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Seattle and their backers are listed below.

Xealth Funding: $50M Raised, IPO (2025)

Xealth funding overview

Xealth at a glance

Frequently asked about Xealth funding

Companies related to Xealth (33)

Browse related funding lists (6)